The miR-26b-5p/KPNA2 Axis Is an Important Regulator of Burkitt Lymphoma Cell Growth
Authors:
- Fubiao NiuFNFubiao Niu
- Marta KazimierskaMKMarta Kazimierska
- Ilja M. NolteINIlja M. Nolte
- Miente Martijn TerpstraMTMiente Martijn Terpstra
- Debora de JongDJDebora de Jong
- Jasper KoertsJKJasper Koerts
- Tineke van der SluisTSTineke van der Sluis
- Bea RutgersBRBea Rutgers
- Ryan M. O’connellRORyan M. O’connell
- Klaas KokKlaas Kok
- Anke van Den BergAnke van Den Berg
- Agnieszka Dzikiewicz-KrawczykADAgnieszka Dzikiewicz-Krawczyk
Open Access
Abstract
The expression of several microRNAs (miRNAs) is known to be changed in Burkitt lymphoma (BL), compared to its normal counterparts. Although for some miRNAs, a role in BL was demonstrated, for most of them, their function is unclear. In this study, we aimed to identify miRNAs that control BL cell growth. Two BL cell lines were infected with lentiviral pools containing either 58 miRNA inhibitors or 44 miRNA overexpression constructs. Eighteen constructs showed significant changes in abundance over time, indicating that they affected BL growth. The screening results were validated by individual green fluorescent protein (GFP) growth competition assays for fifteen of the eighteen constructs. For functional follow-up studies, we focused on miR-26b-5p, whose overexpression inhibited BL cell growth. Argonaute 2 RNA immunoprecipitation (Ago2-IP) in two BL cell lines revealed 47 potential target genes of miR-26b-5p. Overlapping the list of putative targets with genes showing a growth repression phenotype in a genome-wide CRISPR/Cas9 knockout screen, revealed eight genes. The top-5 candidates included EZH2, COPS2, KPNA2, MRPL15, and NOL12. EZH2 is a known target of miR-26b-5p, with oncogenic properties in BL. The relevance of the latter four targets was confirmed using sgRNAs targeting these genes in individual GFP growth competition assays. Luciferase reporter assay confirmed binding of miR-26b-5p to the predicted target site for KPNA2, but not to the other genes. In summary, we identified 18 miRNAs that affected BL cell growth in a loss- or gain-of-function screening. A tumor suppressor role was confirmed for miR-26b-5p, and this effect could at least in part be attributed to KPNA2, a known regulator of OCT4, c-jun, and MYC.Keywords
Funding Information
- National Science Centre Poland (2016/23/D/NZ1/01611 to A.D.K.)
- China Scholarship Council (CSC); University Medical Center of Groningen (601317 (awarded to F.N.))
- The Cock-Hadders foundation (2018 (to F.N.))
This publication has 58 references indexed in Scilit:
- KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3aCell Death & Disease, 2013
- High-throughput assessment of microRNA activity and function using microRNA sensor and decoy librariesNature Methods, 2012
- MicroRNA signatures in B-cell lymphomasBlood Cancer Journal, 2012
- Rapid Generation of MicroRNA Sponges for MicroRNA InhibitionPLOS ONE, 2012
- The role of miR-26 in tumors and normal tissues (Review)Oncology Letters, 2011
- MiRNA profiling in B non‐Hodgkin lymphoma: a MYC‐related miRNA profile characterizes Burkitt lymphomaBritish Journal of Haematology, 2010
- A high throughput experimental approach to identify miRNA targets in human cellsNucleic Acids Research, 2009
- Widespread microRNA repression by Myc contributes to tumorigenesisNature Genetics, 2007
- Characteristic chromosomal abnormalities in biopsies and lymphoid‐cell lines from patients with burkitt and non‐burkitt lymphomasInternational Journal of Cancer, 1976
- A sarcoma involving the jaws in african childrenBritish Journal of Surgery, 1958